Likewise, in the comparison of the control and the CP group, the significantly upregulated LRATD2 is the main inducer of neuroendocrine tumor, which induces glioma by the cell cycle or Akt/GSK-3β/βpathways [47,48,49]. Here, LRATD2 is linked to glioma.